Control systems and decision making for antibody production.
about
ZNF385B is characteristically expressed in germinal center B cells and involved in B-cell apoptosisThe germinal center antibody response in health and diseaseAnti-rods/rings autoantibody generation in hepatitis C patients during interferon-α/ribavirin therapyPredominant Role of Plasmacytoid Dendritic Cells in Stimulating Systemic AutoimmunityDefects in Germinal Center Selection in SLETranslating transitions - how to decipher peripheral human B cell developmentThymic B Cells and Central T Cell ToleranceContribution of Toll-like receptor signaling to germinal center antibody responsesS1PR2 links germinal center confinement and growth regulationT Helper Subsets, Peripheral Plasticity, and the Acute Phase Protein, α1-AntitrypsinMemory B cells in transplantationResolve, revise, and relax: the 3 Rs of B cell repertoire adjustmentHybrid integrated label-free chemical and biological sensorsRgs13 constrains early B cell responses and limits germinal center sizesTh17 effector cells support B cell responses outside of germinal centresYoung lives lost as B cells falter: what we are learning about antibody responses in malaria.Humanized Immunoglobulin Mice: Models for HIV Vaccine Testing and Studying the Broadly Neutralizing Antibody Problem.Treatment of primary Sjögren syndrome.Passive broad-spectrum influenza immunoprophylaxisProtective neutralizing influenza antibody response in the absence of T follicular helper cells.IL-21 promotes late activator APC-mediated T follicular helper cell differentiation in experimental pulmonary virus infection.The sphingosine 1-phosphate receptor S1P₂ maintains the homeostasis of germinal center B cells and promotes niche confinement.AID-induced remodeling of immunoglobulin genes and B cell fate.FoxP3+ regulatory T cells promote influenza-specific Tfh responses by controlling IL-2 availability.Epstein-Barr virus ensures B cell survival by uniquely modulating apoptosis at early and late times after infectionSimultaneous Subcutaneous and Intranasal Administration of a CAF01-Adjuvanted Chlamydia Vaccine Elicits Elevated IgA and Protective Th1/Th17 Responses in the Genital Tract.Integrin-mediated interactions between B cells and follicular dendritic cells influence germinal center B cell fitnessRestricted VH/VL usage and limited mutations in gluten-specific IgA of coeliac disease lesion plasma cells.Redemption of autoantibodies on anergic B cells by variable-region glycosylation and mutation away from self-reactivity.Human T-Cell Development and Thymic Egress: An Infectious Disease PerspectiveShp1 signalling is required to establish the long-lived bone marrow plasma cell pool.Lymphoadenopathy during lyme borreliosis is caused by spirochete migration-induced specific B cell activationDiacylglycerol kinase ζ limits B cell antigen receptor-dependent activation of ERK signaling to inhibit early antibody responsesPhorbol myristate acetate, but not CD40L, induces the differentiation of CLL B cells into Ab-secreting cells.Progression from IgD+ IgM+ to isotype-switched B cells is site specific during coronavirus-induced encephalomyelitis.Modelling the influence of foot-and-mouth disease vaccine antigen stability and dose on the bovine immune response.The BCL6 RD2 domain governs commitment of activated B cells to form germinal centers.Host differences in influenza-specific CD4 T cell and B cell responses are modulated by viral strain and route of immunization.IKK-induced NF-κB1 p105 proteolysis is critical for B cell antibody responses to T cell-dependent antigen.The dysfunction of T follicular helper cells
P2860
Q24297919-CF05F38B-7E68-4228-8401-798C6FDB537EQ26745929-A48AB291-EDB9-43D8-8685-66EE786C920FQ26766115-FE8557DE-DE4B-4A3E-88CD-AA52544FF61AQ26777199-06C540B3-086C-4A7F-8BBE-9615742820B7Q26796041-FED37049-6E8C-4106-A0FB-B9AE774FBA7EQ26799037-C4998828-DFA0-442E-BDAF-E3A4AC6FEE53Q26800127-716C1A44-0B5C-4E66-B702-7148824CED4EQ26829061-F769FBF7-1507-4E49-9D3E-8614A62C4A20Q26829249-82E06959-4B39-4C48-B6DD-A9FFCAC90565Q26829272-EDD0EEC2-82E3-4EC6-B9D5-21C6DE6478F8Q26829296-4C6484D9-A143-4760-A9B9-F07E5C64031BQ26852927-8CFE2DAC-B0CA-4326-97A3-687359B20F60Q27027536-DC502D9A-FA3F-41C7-A966-62A9FF9C0566Q27331880-A0F9CD19-EB12-42AA-BA19-4DFD2F0CD023Q27335276-186F516E-42D9-4869-B07D-82B8C19DE1B9Q27687235-B4405DC7-D2D9-47AC-BBF3-3DE77F2A0D04Q30234773-DED27EF8-DAE0-465D-B1CB-9C0F68B1125EQ30249011-3C7D319E-46F0-4DD8-B6DB-1C2DE9BDB4EAQ30367936-318392D3-CF2C-4820-BE27-24F55F7F9BD4Q30394708-0E6A1A47-0983-4F2F-AD52-3B20F324D3CBQ30410330-FE63367D-A0D1-4ADA-9A7F-1A8B7316991FQ30503547-822400FF-FF8D-44A0-AB03-44BD79DC14ECQ33576896-0BD55207-90FF-4B82-88CE-E982F947AEB6Q33580878-94495A67-18D3-4DEA-83CE-246F03525EB3Q33658144-83CA3CEC-3081-440B-A0F6-E4D4A914710FQ33694896-CBC4AF17-6AE9-4AD8-A619-505D2C0CB056Q33751976-5CC4F7B7-CAD3-458B-931C-726A60761A0BQ33764385-17031C72-108E-4FF3-A7CC-B81FDCB27C97Q33835200-2A2C1486-2337-490A-80BC-CC0ABB8DA8A6Q33848181-71C5C085-9F0D-4FBA-904E-873248FF38FDQ33851655-CC0D1AB7-FE49-4A1D-A58D-A321F98F8B85Q33921243-AE3F02B8-6C7A-47B3-A4B8-D56CA125F467Q33940462-2FA7C3BA-6427-4ACB-80AE-5B26430B1ADEQ34052050-158E1AF9-C579-49E6-865B-140B552ACDFDQ34059107-6FF9E600-50CA-4A82-AADF-9C884F39276FQ34170015-2B37BD1F-49AB-4708-A0A2-FDA5D45CF113Q34175167-20D942B1-494F-4797-B3DF-0664346B8C2DQ34212258-899267AC-C085-40F8-9B0F-9F3426E3BE2FQ34230541-D21CB44B-5679-4AEC-9B9D-DA9945F8F1CBQ34252448-4EF5368E-7F12-4F94-ABB9-A7C554A6286A
P2860
Control systems and decision making for antibody production.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Control systems and decision making for antibody production.
@en
Control systems and decision making for antibody production.
@nl
type
label
Control systems and decision making for antibody production.
@en
Control systems and decision making for antibody production.
@nl
prefLabel
Control systems and decision making for antibody production.
@en
Control systems and decision making for antibody production.
@nl
P2093
P2860
P356
P1433
P1476
Control systems and decision making for antibody production
@en
P2093
Carola G Vinuesa
Katrina L Randall
Robert Brink
P2860
P304
P356
10.1038/NI.1900
P407
P577
2010-07-20T00:00:00Z